Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006.

Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006.

Item

http://www.wikidata.org/entity/Q39976307

Q39976307

about

Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006.

Item

http://www.wikidata.org/entity/Q39976307

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Histamine H2-Receptor Antagoni ...... Examination Survey, 2001-2006.

@en

Histamine H2-Receptor Antagoni ...... Examination Survey, 2001-2006.

@nl

type

Item

label

Histamine H2-Receptor Antagoni ...... Examination Survey, 2001-2006.

@en

Histamine H2-Receptor Antagoni ...... Examination Survey, 2001-2006.

@nl

prefLabel

Histamine H2-Receptor Antagoni ...... Examination Survey, 2001-2006.

@en

Histamine H2-Receptor Antagoni ...... Examination Survey, 2001-2006.

@nl

P1476

Histamine H2-Receptor Antagoni ...... Examination Survey, 2001-2006.

@en

P2093

Huafeng Shen

http://www.w3.org/2001/XMLSchema#string

Suthat Liangpunsakul

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological interventions for non-ulcer dyspepsia

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Modulation of neutrophil oxidative burst via histamine receptors

Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.

H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.

Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in mice

Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications.

Brand name and generic proton pump inhibitor prescriptions in the United States: insights from the national ambulatory medical care survey (2006-2010).

P304

596-601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MCG.0000000000000503

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26905606

http://www.w3.org/2001/XMLSchema#string

P932

4935666

http://www.w3.org/2001/XMLSchema#string

Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006.

about

Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932